Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9

Oncology Reports

Volumn 26, Issue 1, 2011, Pages 237-245

  Yuan, Zhu ^a,b   Sanders, Andrew J ^a   Ye, Lin ^a   Wang, Y U ^b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cyclin D1; Growth; Human antigen R; Invasion; MMP 9

Indexed keywords

CYCLIN D1; GELATINASE B; HU ANTIGEN; HUMAN ANTIGEN R; MESSENGER RNA; RIBOZYME; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

ANTIGENS, SURFACE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RNA, CATALYTIC; RNA-BINDING PROTEINS; TRANSGENES; WOUND HEALING;

EID: 79955854286     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1271     Document Type: Article

References (36)

1. Ma WJ, Cheng S, Campbell C, Wright A and Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271: 8144-8151, 1996. (Pubitemid 26108641)
2. Ma WJ and Furneaux H: Localization of the human HuR gene to chromosome 19p13.2. Hum Genet 99: 32-33, 1997.
3. Yao KM, Samson ML, Reeves R and White K: Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J Neurobiol 24: 723-739, 1993. (Pubitemid 23157139)
4. Peng SS, Chen CY, Xu N and Shyu AB: RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17: 3461-3470, 1998. (Pubitemid 28279518)
5. Okano HJ and Darnell RB: A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 17: 3024-3037, 1997.
6. Brennan CM and Steitz JA: HuR and mRNA stability. Cell Mol Life Sci 58: 266-277, 2001. (Pubitemid 32217358)
7. Inoue M, Muto Y, Sakamoto H and Yokoyama S: NMR studies on functional structures of the AU-rich element-binding domains of Hu antigen C. Nucleic Acids Res 28: 1743-1750, 2000. (Pubitemid 30199307)
8. Beckel-Mitchener AC, Miera A, Keller R and Perrone-Bizzozero NI: Poly(A) tail length-dependent stabilization of GAP-43 mRNA by the RNA-binding protein HuD. J Biol Chem 277: 27996-28002, 2002. (Pubitemid 34966749)
9. Myer VE, Fan XC and Steitz JA: Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J 16: 2130-2139, 1997. (Pubitemid 27170973)
10. Bakheet T, Williams BR and Khabar KS: ARED 2.0: an update of AU-rich element mRNA database. Nucleic Acids Res 31: 421-423, 2003. (Pubitemid 36150418)
11. Antic D and Keene JD: Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 61: 273-278, 1997. (Pubitemid 27382301)
12. Fan XC and Steitz JA: Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17: 3448-3460, 1998. (Pubitemid 28279517)
13. Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415, 2003.
14. Jiang WG, Davies G and Fodstad O: Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection. Biochem Biophys Res Commun 330: 253-262, 2005. (Pubitemid 40394960)
15. Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer 7: 71, 2008.
16. Sanders AJ, Parr C, Mason MD and Jiang WG: Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro. Int J Mol Med 20: 613-619, 2007.
17. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE and Puntis MC: Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Res 55: 5043-5048, 1995.
18. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF and Puntis MC: Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer 71: 744-752, 1995.
19. Jiang WG, Hiscox SE, Parr C, et al: Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res 5: 3695-3703, 1999.
20. Kim JK and Diehl JA: Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 220: 292-296, 2009.
21. Yao J, Xiong S, Klos K, et al: Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20: 8066-8074, 2001. (Pubitemid 34028331)
22. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
23. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004. (Pubitemid 39070849)
24. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL and Gorospe M: Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23: 3092-3102, 2004. (Pubitemid 39093603)
25. Wang W, Caldwell MC, Lin S, Furneaux H and Gorospe M: HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19: 2340-2350, 2000. (Pubitemid 30259015)
26. Wang W, Yang X, Cristofalo VJ, Holbrook NJ and Gorospe M: Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol 21: 5889-5898, 2001. (Pubitemid 32737806)
27. Sheflin LG, Zou AP and Spaulding SW Androgens regulate the binding of endogenous HuR to the AU-rich 3′UTRs of HIF-1alpha and EGF mRNA. Biochem Biophys Res Commun 322: 644-651, 2004. (Pubitemid 39490351)
28. Esnault S and Malter JS: Hyaluronic acid or TNF-alpha plus fibronectin triggers granulocyte macrophage-colony-stimulating factor mRNA stabilization in eosinophils yet engages differential intracellular pathways and mRNA binding proteins. J Immunol 171: 6780-6787, 2003. (Pubitemid 37532112)
29. Levy NS, Chung S, Furneaux H and Levy AP: Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423, 1998. (Pubitemid 28144735)
30. Tran H, Maurer F and Nagamine Y: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 23: 7177-7188, 2003. (Pubitemid 37211000)
31. Lopez de Silanes I, Zhan M, Lal A, Yang X and Gorospe M: Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101: 2987-2992, 2004. (Pubitemid 38327723)
32. Lopez de Silanes I, Lal A and Gorospe M: HuR: post-transcriptional paths to malignancy. RNA Biol 2: 11-13, 2005.
33. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
34. Jin M, Inoue S, Umemura T, et al: Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer 34: 207-218, 2001. (Pubitemid 33010796)
35. Barnes DM and Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1-15, 1998. (Pubitemid 29056081)
36. Shamma A, Doki Y, Shiozaki H, et al: Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 16: 261-266, 2000.